The greater elevation of IFN-α levels in severe cases was also reported in the second study from China [5] and the potential significance of this IFN-α elevation in relation to the efficacy of dexamethasone (DEX) in COVID-19 therapy will be discussed below. This evidence concerns the gene IFNA1 and COVID-19.